Direkt zum Inhalt
Merck
  • Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Glycoconjugate journal (2009-12-31)
Mercè Padró, José A Castillo, Livia Gómez, Jesús Joglar, Pere Clapés, Carme de Bolós
ZUSAMMENFASSUNG

Iminosugars are monosaccharide analogues that have been demonstrated to be specific inhibitors for glycosidases and are currently used therapeutically in several human disorders. N-alkylated derivatives of D-fagomine and (2R,3S,4R,5S)-2-(hydroxymethyl)-5-methylpyrrolidine-3,4-diol with aliphatic chains were tested in eight human cancer cell lines to analyze their cytotoxicity and the inhibitory effect in the activities of specific glycosidases. Results indicate that these compounds were more cytotoxic as the length of the alkyl chain increases. N-dodecyl-D-fagomine inhibited specifically the alpha-D-glucosidase activity in cell lysates, whereas no effect was detected in other glycosidases. The N-dodecyl derivative of (2R,3S,4R,5S)-2-(Hydroxymethyl)-5-methylpyrrolidine-3,4-diol induced specific inhibition against alpha-L-fucosidase in cell lysates. Our results indicated that the length of the alkyl chain linked to the iminosugars determine their cytotoxicity as well as the inhibitory effect on the enzymatic activities of specific glycosidases, in human cancer cell lines.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
4-Nitrophenyl α-L-Fucopyranosid, ≥98% (TLC)
Sigma-Aldrich
4-Nitrophenyl β-D-Fucopyranosid, ≥98% (TLC)